Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastasses from colorectal carcinomas

Annals of Oncology

Volumn 12, Issue 3, 2001, Pages 321-325

  Lorenz, M ^a   Mueller, H H ^b   Mattes, E ^c   Gassel, H J ^d   Junginger, T ^e   Saeger, H D ^f   Schramm, H ^c   Staib Sebler, E ^a   Vetter, G ^a   Heinrich, S ^a   Kohne C H ^g  

^a GOETHE UNIVERSITY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c General Hospital   (Germany)

^d Luitpold Hospital   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^g ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

24 Hour high dose 5 FU FA; Colorectal hepatic metastases; HAI; Hepatic artery infusion; Phase II study

Indexed keywords

CREATININE; FLUOROURACIL; FOLINIC ACID; HEMOGLOBIN; HEPARIN; TROPISETRON; UREA;

ADULT; AGED; AGRANULOCYTOSIS; ALOPECIA; ARTICLE; BLEEDING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIARRHEA; DRUG DELIVERY SYSTEM; DRUG INFUSION; DRUG MEGADOSE; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; FEVER; HEART FAILURE; HUMAN; IMPLANTATION; INFECTION; LEUKOPENIA; LIVER METASTASIS; MALE; NAUSEA; PAIN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0035070205     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011181700258     Document Type: Article

References (17)

1. Liver metastases from colorectal carcinoma: Incidence, resectability, and survival results
2. Pharmacological rationale for regional drug delivery
3. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2′-deoxyuridine and 5-fluorouracil
4. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer
5. Randomized, multicenter trial of 5-fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients liver metastases from colorectal carcinoma
6. Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: Results of a randomized trial in patients with advanced colorectal cancer
7. A pilot study on intense weekly 24-hour intra-arterial infusion with 5-fluorouracil and folinic acid for colorectal liver metastases
8. Hepatic artery infusion pumps: Cannulation techniques and other surgical considerations
9. Reporting results of cancer treatment
10. Toxicity grading systems. A comparison between the WHO scoring system and the Common Toxicity Criteria when used for nausea and vomiting
11. Nonparametric estimation from incomplete observation
12. Arterial therapy of hepatic colorectal metastases
13. In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C mediated vasoconstriction of vascular smooth muscle
14. Arterial perfusion abnormalities of the liver after hepatic arterial infusion chemotherapy and their correlation with changes in the metastases: Evaluation with CT and angiography
15. A randomized trial of infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer
16. Pharmacology of regional chemotherapy of colorectal liver metastases
17. A phase II study of regional 5-fluorouracil infusion with intravenous folinic acid for colorectal liver metastases